High remnant lipoprotein levels in patients with variant angina

Clinical Cardiology

Volumn 27, Issue 6 SUPPL. 3, 2004, Pages 338-342

  Miwa, Kunihisa ^a,b   Makita, Toshinori ^a   Ishii, Katsuhisa ^a   Okuda, Nobuaki ^a   Taniguchi, Ataru ^a  

^a Kahsai Electric Power Hospital   (Japan)

^b HAMAMATSU ROSAI HOSPITAL   (Japan)

Author keywords

Coronary vasospasm; Remnant lipoproteins; Variant angina; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC REGULATION; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; SMOKING; STATISTICAL SIGNIFICANCE; VARIANT ANGINA PECTORIS;

EID: 2542584599     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270608     Document Type: Article

References (30)

1. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousidan S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. J Am Med Assoc 1986;256:2835-2838
2. Frick MH, Elo O, Haapa K, Heinonen OP, Hansalma P, Helo P, Huttunen JK, Kaitaneimi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Maittari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA: Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-1245
3. Miwa K, Fujita M, Miyagi Y, Inoue H, Sasayama S: High-density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm. Clin Cardiol 1995;18:267-272
4. Miwa K, Yoshida N, Nakagawa K, Inoue H: High-density lipoprotein particles are large in patients with variant angina. Cardiovasc Res 1998;37:729-737
5. Miwa K, Miyagi Y, Fujita M: Susceptibility of plasma low-density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol 1995;26:632-638
6. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H: Vitamin E deficiency in variant angina. Circulation 1996;94:14-18
7. Mead MG, Dangerfield WG: The investigation of "midband" lipoproteins using polyacrylamide gel electrophoresis. Clin Chim Acta 1974;51:173-182
8. Miwa K, Nakagawa K, Suzuki K, Inoue H: Detection of the "midband" lipoprotein in patients with coronary artery spasm. Clin Cardiol 2001;24:219-224
9. Patsch JR, Miesenblock G, Hopferwiesser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W: Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-1345
10. Zilversmit DB: Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:53-58
11. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsuyama T, Ohta Y, Nakano T, Nakajima K, Yasue H: Remnants of chyromicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis 1998;137:341-349
12. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsuyama T, Sugiyama S, Nakano T, Nakajima K, Yasue H: Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 1998;97:2519-2526
13. Kugiyama K, Motoyama T, Doi H, Kawano H, Hirai N, Soejima H, Miyao Y, Takazoe K, Moriyama Y, Mizuno Y, Tsunoda R, Ogawa H, Sakamoto T, Sugiyama S, Yasue H: Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoprotein levels. J Am Coll Cardiol 1999;33:1512-1518
14. Miwa K, Fujita M, Ejiri M, Sasayama S: Comparative sensitivity of intracoronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris. Am Heart J 1990;120:544-550
15. Friedwald WT, Levy RI, Frederickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-508
16. WHO Expert Committee in Diabetes Mellitus: Second report. WHO Tech Rep Ser 1980;646:1-80
17. Fazio S, Lee Y-L, Ji Z-S, Rall SC Jr: Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J Clin Invest 1993;92:1497-1503
18. Patsch JR, Gotto AM, Olivecrona T, Eisenberg S: Formation of high-density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA 1978;75:4519-4523
19. Hodis HN: Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 1999;99:2852-2854
20. Inoue T, Saniabadi AR, Matsunaga R, Hoshi K, Yaguchi I, Morooka S: Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis 1998;139:363-367
21. Doi H, Kugiyama K, Oka H, Sugiyama S, Ogata N, Koide S, Nakamura S, Yasue H: Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 2000;102:670-676
22. Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R: Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 1981;64:1174-1184
23. Steiner G, Schwartz L, Shumak S, Poapst M: The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 1987;75:124-130
24. Topping DL, Dwyer T, Weller RA: Peripheral vascular disease in cigarette smokers and impaired hepatic metabolism of lipoprotein remnants. Lancet 1977;2:1327-1328
25. Sugiishi M, Takatsu F: Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-79
26. Shinozaki K, Suzuki M, Ikebuchi M, Tasaki H, Hara Y, Tsushima M, Harano Y: Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 1995;92:1749-1757
27. Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K, Nakai Y: Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000;23:1766-1769
28. Sakata K, Miho N, Shirotani M, Yoshida H, Takada Y, Takada A: Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis 1998;136:225-231
29. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H: Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-272
30. i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest 1995;95:1457-1463